FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

19861711000001102: Valsartan 160mg tablets (Aspire Pharma Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 08-Feb 2012. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
67068801000001119 Valsartan 160mg tablets (Aspire Pharma Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
67068901000001113 Valsartan 160mg tablets (Aspire Pharma Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Valsartan 160mg tablets (Aspire Pharma Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Valsartan 160mg tablets (Aspire Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Valsartan 160mg tablets (Aspire Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Valsartan 160mg tablets (Aspire Pharma Ltd) Is a Product containing precisely valsartan 160 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Valsartan 160mg tablets (Aspire Pharma Ltd) Has active ingredient Valsartan false Inferred relationship Existential restriction modifier
Valsartan 160mg tablets (Aspire Pharma Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Valsartan 160mg tablets (Aspire Pharma Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Valsartan 160mg tablets (Aspire Pharma Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Valsartan 160mg tablets (Aspire Pharma Ltd) Has specific active ingredient Valsartan true Inferred relationship Existential restriction modifier
Valsartan 160mg tablets (Aspire Pharma Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Valsartan 160mg tablets (Aspire Pharma Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Valsartan 160mg tablets (Aspire Pharma Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Valsartan 160mg tablets (Aspire Pharma Ltd) 28 tablet 4 x 7 tablets Has AMP True Valsartan 160mg tablets (Aspire Pharma Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start